KLRK1 and cancer: These ligands can activate natural killer (NK) and cytotoxic T cells by binding to the NKG2D, and subsequently contribute to cell-mediated cytolysis and clearance of cancer [38], suggesting that tumor cells overexpressing these ligands are more susceptible to cell-mediated immune surveillance.